Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
11 pending office actions • 8 art units • 10 examiners • 0 of 11 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Whitehead Institute for Biomedical Research is currently managing 11 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 10 distinct examiners and 8 distinct art units. This broad distribution indicates that the institute's applications are being reviewed by a large group of examiners across many different technical classifications. The ratio of 11 actions to 10 examiners highlights a nearly one-to-one assignment of matters to personnel in the Biotechnology & Pharmaceuticals sector.
The busiest examiner for the portfolio is NOBLE, MARCIA STEPHENS, who is responsible for 2 pending office actions. This is the only examiner among the 10 distinct examiners to handle more than one pending matter. With 8 distinct art units involved for 11 pending office actions, the portfolio shows a high degree of technical diversity. This requires the institute to coordinate its efforts across 8 specialized divisions at the patent office to manage the current pending workload effectively.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (27%) |
| §112 only | 3 (27%) |
| Multi-statute (no §101) | 5 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOBLE, MARCIA STEPHENS | 2 | 67.0% | +39.9% |
| LEE, JAE W | 1 | 65.8% | +38.6% |
| GROOMS, TIFFANY NICOLE | 1 | 57.8% | +46.3% |
| MEAH, MOHAMMAD Y | 1 | 70.8% | +42.7% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 42.9% | +57.1% |
| YOUTCHOM PENDIE, EMMANUEL LED | 1 | 66.7% | +40.0% |
| HUDSON, AMY ROSE | 1 | 74.9% | +11.5% |
| DHAR, MATASHA | 1 | 43.3% | +45.7% |
| PERREIRA, MELISSA JEAN | 1 | 52.0% | +25.8% |
| VISHNYAKOVA, ELENA VLADIMIROVNA | 1 | 65.8% | +51.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18916572 | REPROGRAMMING OF SOMATIC CELLS | NOBLE, MARCIA STEPHENS | — |
| 18773428 | METHODS OF EDITING DNA METHYLATION | LEE, JAE W | — |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | GROOMS, TIFFANY NICOLE | — |
| 18038943 | MODULATING TRANSCRIPTIONAL CONDENSATES | BUCHANAN, BAILEY CHEYENNE | — |
| 17878774 | CDC20 VARIANTS RESISTANT TO ANTI-MITOTIC DRUGS AND RELATED METHODS AND COMPOSITIONS | YOUTCHOM PENDIE, EMMANUEL LED | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17869611 | METHODS FOR LABELING AND TARGETING CELLS | HUDSON, AMY ROSE | 124d overdue |
| 17318921 | THE USE OF CHOLINE SUPPLEMENTATION AS THERAPY FOR APOE4-RELATED DISORDERS | VISHNYAKOVA, ELENA VLADIMIROVNA | 42d overdue |
| 18350985 | ENZYMATIC SYNTHESIS OF KAVALACTONES AND FLAVOKAVAINS | MEAH, MOHAMMAD Y | 9d |
| 18916572 | REPROGRAMMING OF SOMATIC CELLS | NOBLE, MARCIA STEPHENS | — |
| 18773428 | METHODS OF EDITING DNA METHYLATION | LEE, JAE W | — |
| 18635153 | METHODS FOR REPROGRAMMING SOMATIC CELLS | NOBLE, MARCIA STEPHENS | — |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | GROOMS, TIFFANY NICOLE | — |
| 18038943 | MODULATING TRANSCRIPTIONAL CONDENSATES | BUCHANAN, BAILEY CHEYENNE | — |
| Art Unit | Apps |
|---|---|
| 1632 | 2 |
| 1637 | 1 |
| 1652 | 1 |
| 1682 | 1 |
| 1647 | 1 |
| 1636 | 1 |
| 1618 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18916572 | REPROGRAMMING OF SOMATIC CELLS | NOBLE, MARCIA STEPHENS | — | §103§112 | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18773428 | METHODS OF EDITING DNA METHYLATION | LEE, JAE W | — | §103§112 | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18635153 | METHODS FOR REPROGRAMMING SOMATIC CELLS | NOBLE, MARCIA STEPHENS | 1632 | §112 | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | GROOMS, TIFFANY NICOLE | 1637 | §102§103§112 | Non-Final OA | — | Pending | Nov 02, 2023 |
| 18350985 | ENZYMATIC SYNTHESIS OF KAVALACTONES AND FLAVOKAVAINS | MEAH, MOHAMMAD Y | 1652 | §112 | Non-Final OA | 9d | Pending | Jul 12, 2023 |
| 18038943 | MODULATING TRANSCRIPTIONAL CONDENSATES | BUCHANAN, BAILEY CHEYENNE | 1682 | §102§103§112 | Non-Final OA | — | Pending | May 25, 2023 |
| 17878774 | CDC20 VARIANTS RESISTANT TO ANTI-MITOTIC DRUGS AND RELATED METHODS AND COMPOSITIONS | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | §102§103 | Non-Final OA | — | Pending | Aug 01, 2022 |
| 17869611 | METHODS FOR LABELING AND TARGETING CELLS | HUDSON, AMY ROSE | 1636 | §112 | Final Rejection | 124d overdue | Pending | Jul 20, 2022 |
| 17588038 | IN VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME | DHAR, MATASHA | 1632 | §103 | Non-Final OA | — | Pending | Jan 28, 2022 |
| 17611560 | METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS | PERREIRA, MELISSA JEAN | 1618 | §103 | Non-Final OA | — | Pending | Nov 15, 2021 |
| 17318921 | THE USE OF CHOLINE SUPPLEMENTATION AS THERAPY FOR APOE4-RELATED DISORDERS | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §103 | Final Rejection | 42d overdue | Pending | May 12, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial